<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2024, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 19 Jan 2023 09:37:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Complete Merger</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+and+Ayala+Pharmaceuticals+Complete+Merger/21088854.html</guid>
   <pubDate>Thu, 19 Jan 2023 09:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Advaxis+Updates+on+the+Phase+1+Clinical+Trial+of+ADXS-504+for+the+Treatment+of+Early+Prostate+Cancer/21064894.html</guid>
   <pubDate>Thu, 12 Jan 2023 08:04:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04794336</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10557543</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</guid>
   <pubDate>Wed, 19 Oct 2022 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</guid>
   <pubDate>Wed, 19 Oct 2022 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</guid>
   <pubDate>Wed, 19 Oct 2022 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</guid>
   <pubDate>Wed, 19 Oct 2022 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
  <item>
   <title>Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement</title>
   <link>http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Advaxis+and+Ayala+Pharmaceuticals+Enter+into+Merger+Agreement/20718457.html</guid>
   <pubDate>Wed, 19 Oct 2022 06:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ADXS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ADXSD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AYLA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02269150</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47615966</category>
   	  </item>
 </channel>
</rss>
